NWBO is between a rock and a hard place. Why would BP make any investment now? Not. Simply because LP's asking price is too high. Remember LP's statement that "all BP brings to the table is a check book."
IMHO, LP does not want to deal or sell out on the cheap. She is confident in what she has. So, it is a trade-off between cheap deals with BP which greatly impacts future value and toxic financing. She has opted to go the toxic financing route because she thinks net-net that is a better alternative than a cheap BP sell out on a JV, licensing , BO, etc., deal. After all is said and done, if this is successful, as she is obviously confident that it will be, the MC will take care of itself and nullify all these toxic financings and current MC. BP is waiting too.
LP is going for broke and she is confident from what she knows with the complement of experts she has at hand: SAB, PIs, professional statisticians, etc. She must believe the odds are heavily weighted in her favour. LL has not distanced herself from NWBO as she delivered the 2018 spring refresh data highlights at SNO. All indications are that DC VAX is effective, more or less, across the glioblastoma spectrum.
It is too late for LP to backtrack and discount her very likely high price to entice BP. If she did so, BP would smell a rat and surmise that LP wants to unload and salvage something before unveiling. So, prior to unblinding and top-line revelation, there is no deal. No BP would step up now without seeing unblinded data unless they were persuaded by the data and info LP has short of unblinding. My view is that BP won't bite without seeing unblinded data. JMHO.
News 
Market Data 
Discover 
AI
